The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer

Citation

Barbour, A, Samra, J, Haghighi, K et al. 2020, 'The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer', Annals of Surgical Oncology, vol. Online.

Year

2020

Fields of Research

  • Surgery
  • Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)
  • Chemotherapy

Updated:  20 June 2021 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers